Development of Lipid Nanocarriers for Tuberculosis Treatment: Evaluation of Suitable Excipients and Nanocarriers.
Hädrich G, Vaz GR, Boschero R, Appel AS, Ramos C, Halicki PCB, Bidone J, Teixeira HF, Muccillo-Baisch AL, Dal-Bó A, Silva Pinto L, Dailey LA, Da Silva PEA, Ramos DF, Dora CL.
Hädrich G, et al. Among authors: vaz gr.
Curr Drug Deliv. 2021;18(6):770-778. doi: 10.2174/1567201818666210212092112.
Curr Drug Deliv. 2021.
PMID: 33583376